The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
I am a reproductive biologist investigating biological mechanisms that play a role in common women�s health disorders including endometriosis, uterine fibroids, menstrual disorders and reproductive cancers.
The Effects Of Dietary And Lifestyle Interventions Among Pregnant Women Who Are Overweight Or Obese On Longer-term Maternal And Early Childhood Outcomes: An Individual Participant Data (IPD) Meta-analysis
Funder
National Health and Medical Research Council
Funding Amount
$287,317.00
Summary
Obesity affects 50% of pregnant women, and is associated with an increased risk of adverse pregnancy and birth outcomes. In the longer-term, maternal obesity predicts high infant birth weight and future child obesity. We will combine and analyse randomised controlled trial data available world-wide through an individual participant data meta-analysis to evaluate the effect of antenatal dietary intervention among women who are overweight or obese on longer-term maternal and child health.
Fetal Middle Cerebral Artery Doppler To Time Second And Subsequent Fetal Transfusions For Red Cell Alloimmunisation.
Funder
National Health and Medical Research Council
Funding Amount
$449,585.00
Summary
Blood group incompatability between a mother and her unborn baby can result in the production of antibodies that can damage the baby's red blood cells, causing anaemia. Treatment involves a procedure to transfuse blood to the baby while in the mother's uterus, which often needs to be repeated several times during a pregnancy. This randomised trial will assess if an ultrasound examination can be used to time second or subsequent fetal transfusions, and the impact this has on infant health.
Preventing Gestational Diabetes Mellitus Using A Home-based Supervised Exercise Program During Pregnancy
Funder
National Health and Medical Research Council
Funding Amount
$766,922.00
Summary
Gestational diabetes mellitus (GDM) is a condition that develops during pregnancy, placing both the mother and her unborn child at risk of numerous health complications. The risk of developing GDM is greatly increased in women with a history of the condition in a previous pregnancy. We aim to investigate the effect of regular supervised home-based exercise commenced during pregnancy on the incidence of GDM, as well as other aspects of maternal and fetal wellbeing.
Targeted Nanoparticle Delivery Of Agents To The Placenta To Treat Preeclampsia
Funder
National Health and Medical Research Council
Funding Amount
$128,224.00
Summary
Preeclampsia, one of the most serious complications of pregnancy, affects around 3-8% of all pregnancies. Sadly, there is no treatment. We have developed a new technique to deliver treatments only to the placenta, sparing the mother and baby from side effects. We will test whether this technique can treat the source of preeclampsia, the placenta, in mouse models and human tissue samples in the laboratory. This work may offer possibilities of new treatments to other pregnancy complications.
Understanding The Role Of Endogenous And Pharmacologic Glycosaminoglycans In Preventing Pre-eclampsia
Funder
National Health and Medical Research Council
Funding Amount
$516,642.00
Summary
Pre-eclampsia (PE) is a serious pregnancy complication that affects the well being of the mother and baby. There is no cure for PE except for delivery of the baby. This may result in delivery much earlier than expected causing a very premature baby. This study investigates substances in the placenta that may be responsible for causing PE. If we can understand how these substances cause the problem of PE, we may be able to find better ways of treating or preventing it.
Maternal Recognition Of Fetal Sex In The Regulation Of Labour
Funder
National Health and Medical Research Council
Funding Amount
$455,821.00
Summary
Preterm birth is the largest cause of death in infants and males are more likely to be born preterm than females. We propose that the intrauterine renin-angiotensin system, the activity of which is regulated in a sex-specific manner, plays a critical role in protecting against preterm labour. Our study will further our understanding of the mechanisms of preterm labour and provide new insight into the sex-specific differences in the prevalence of preterm birth.
Measuring Hypoxia Induced MRNA In Maternal Blood To Determine Acidaemic Status Of Growth Restricted Fetuses In Utero
Funder
National Health and Medical Research Council
Funding Amount
$120,253.00
Summary
Small babies are at greater risk of dying while inside their mothers and the right time to deliver them is an obstetric conundrum. Currently obstetricians rely on ultrasound measures of the baby's wellbeing which do not always correspond with how sick the baby truly is. There is a great need for a more accurate test. This research intends to show that a blood test from the mother can more accurately tell how sick the baby is and provide an answer to when is the best time to deliver the baby.
Tracking blood and blood products for a healthy start to life. This project will aim to coalesce multiple data sources to track blood and blood products from supply to recipient and improve safe and appropriate blood product transfusions for mothers and newborns. Tracking blood will assist in early identification of adverse outcomes. Identification of at-risk women and babies will allow early prevention and treatment.